Treatment of Minute Medullary Thyroid Carcinoma in Multiple Endocrine Neoplasia 2A Families First Diagnosed by DNA Analysis of RET Proto-Oncogene Mutations: A Case Report

Japanese Journal of Clinical Oncology

Volumn 27, Issue 1, 1997, Pages 42-45

  Yamashita, Tomoyuki ^a   Iihara, Masatoshi ^a   Okamoto, Joji ^a   Kanbe, Masako ^a   Ito, Yukio ^a   Kawakami, Makio ^b   Egawa, Shin Ichi ^c   Yamaguchi, Ken ^c   Obara, Takao ^a,b  

^a Departments of Endocrine Surgery   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Medullary thyroid carcinoma; Multiple endocrine neoplasia (MEN) 2A; RET proto oncogene

Indexed keywords

DNA; DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA;

ADRENAL TUMOR; ADULT; ARTICLE; FAMILY HEALTH; GENETICS; HUMAN; HYPERPARATHYROIDISM; MALE; MEDULLARY CARCINOMA; MUTATION; PHEOCHROMOCYTOMA; SIPPLE SYNDROME; THYROID TUMOR; THYROIDECTOMY;

ADRENAL GLAND NEOPLASMS; ADULT; CARCINOMA, MEDULLARY; DNA, NEOPLASM; DROSOPHILA PROTEINS; FAMILY HEALTH; HUMANS; HYPERPARATHYROIDISM; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0031066181     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.1.42     Document Type: Article

References (16)

1. Mulligan LN, Kwok JBJ, Healy CS, Elsdon NJ, Eng C, Gardner E et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-60.
2. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2:851-56.
3. Mathew CGP, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong SL et al. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 1987;328:527-28.
4. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR et al. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by genetic linkage. Nature 1987;328:528-30.
5. Ceccherini I, Hofstra RMW, Luo Y, Stulp RP, Barone V, Stelwagen T et al. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto-oncogene. Oncogene 1994;9:3025-9.
6. Futami H, Egawa S, Tsukada T, Maruyama K, Bandoh S, Noguchi M et al. A novel somatic point mutation of the RET proto-oacogene in tumor tissues of small cell lung cancer patients. Jpn J Cancer Res 1995,86:1127-30.
7. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
8. Decker RA, Peacock ML, Borst MJ, Sweet JD, Thompson NW. Progress in genetic screening of multiple endocrine neoplasia type 2A: Is calcitonin testing obsolete? Surgery 1995;118 257-64.
9. Lips CJM, Landsvater RM, Hoppener JWM, Geerdink RA, Blijham G, van Veen JMJ-S et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 1994;331:828-35.
10. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JB, Gardner E et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet 1994;6:70-4.
11. Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton B et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-50.
12. Howe JR, Norton JA, Wells SA Jr. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long term follow-up. Surgery 1993;114:1070-7.
13. Utiger RD. Medullary thyroid carcinoma, genes, and the prevention of cancer. N Engl J Med 1994;331:870-1.
14. O'Riordain DS, O'Brien T, Weaver AL, Gharib H, Hay ID, Grant CS et al. Medullary thyroid carcinoma in multiple endocrine neoplasia type 2A and 2B. Surgery 1994;116.1017-23.
15. Takai S, Miyauchi A, Matsumoto H, Ikeuchi T, Miki T, Kuma K et al. Multiple endocrine neoplasia type 2 syndromes in Japan Henry Ford Hosp Med J 198432:246-50.
16. Pacini F, Martino E, Romei C, Ceccherini, Basolo F, Iacconi P et al. Treatment of preclinical medullary thyroid carcinoma in MEN 2A gene carrier. Lancet 1994;344:1084-5.